ADSR06 Adapta SR
Implantable Pulse Generator (IPG)
ADSR06 Adapta SR
Information

Device Survival Probability

ADSR01_ADSR03_ADSR06_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr at 135.0 mo                  
% Excluding Normal Battery Depletion 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0                  
% Including Normal Battery Depletion 99.9 99.7 99.5 99.0 98.3 97.2 94.7 88.7 71.7 50.5 27.5 14.6                  
#   72024 62938 55043 47920 41117 34801 28762 21871 12930 5487 876 116                  
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Customer Communications For This Model

  • There are no communications for this model.
Information

Product Characteristics

Generator Type IPG
NBD Code SSIR
Max. Delivered Energy N/A
More
Connector Style 5/6mm UNI
Serial Number Prefix NWN, PWN
Mass 22.5 g
Volume 11.0 cc
Waveform N/A
X-Ray ID PWB, NWN
Hide this content
5/6mm UNI
Information

Estimated Longevity

Amplitude Setting 500 Lead Ω 1000 Lead Ω
Low 2.5 V (A, RV) 7.4 | 8.9* 7.9 | 9.7*
Nominal 3.5 V (A, RV) 6.5 | 7.7* 7.5 | 9.1*
High 5.0 V (A, RV) 5.1 | 5.9* 6.3 | 7.4*
Footnote

*The second longevity numbers provided apply to the N-series Adapta ADSR06 product. The N-series products have increased longevity because of improved electronic circuitry. Click on "Other Articles" for more information on the N-series longevity. Longevity estimates based on the following device usage. Pace/Sense Mode VVI ; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; EGM Prestorage ON ; Upper Sensing Rate 130 ppm; EGM Prestorage ON Time 1 ; Hide this content

Information

Distribution Data

US Market Release2006-07-17
CE Approval Date2005-09-20
Registered USA Implants2891
Estimated Active USA Implants612
Normal Battery Depletions265
US Market Release2006-07-17
CE Approval Date2005-09-20
Estimated WW Distribution10901
Normal Battery Depletions343
Information

Malfunctions (USA)

Therapy Function Not Compromised 2
Electrical Component 2
Therapy Function Compromised 0
Information

Malfunctions (WW)

Therapy Function Not Compromised 2
Electrical Component 2
Therapy Function Compromised 0
Information

EOS Indication

From the point that the ERI is set, the pacemaker will operate at ERI conditions for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Telemetry indication. Rate and mode change to 65 ppm and VVI respectively (VOO/65 with magnet).

Data as of December 1, 2023

www.medtronic.com/productperformance 951051